MedAdvisor Ltd (ASX: MDR) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


MedAdvisor Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $184.36 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 550.33 million
Earnings per share -0.018
Dividend per share N/A
Year To Date Return 55.81%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • MedAdvisor Ltd (ASX: MDR)
    Latest News

    A young woman holding her phone smiles broadly and looks excited, after receiving good news.
    Share Gainers

    Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

    These shares are having a strong session. But why?

    Read more »

    A happy group of workers around a table raise their arms in the air as though celebrating a work achievement. One woman is on her feet with her arm raised in the air in a fist-pumping action.
    Share Gainers

    Why European Lithium, Evolution, MedAdvisor, and REA shares are charging higher

    These ASX shares are having strong days...

    Read more »

    laboratory workers looking disappointed
    Earnings Results

    3 ASX healthcare shares punished following full-year results

    It wasn't so rosy for all those reporting earnings today

    Read more »

    Digitised heart rate and share price chart with man on ipad in background signifying share price
    Technology Shares

    Why the MedAdvisor (ASX:MDR) share price jumped 12% today

    The medication management platform sees strong growth in the US after its "transformational" acquisition 6 months ago.

    Read more »

    Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company
    Share Market News

    The MedAdvisor (ASX:MDR) share price is lifting today. Here's why

    The MedAdvisor (ASX: MDR) share price is surging today after a health program deal was extended. Here are the details.

    Read more »

    hand on touch screen lit up by a share price chart moving higher
    Share Gainers

    Why Brickworks, McPherson's, MedAdvisor, & Premier Investments are storming higher

    Brickworks Limited (ASX:BKW) and McPherson's Ltd (ASX:MCP) are two of four ASX shares storming higher on Thursday...

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Why the Medadvisor (ASX:MDR) share price is up 11% this week

    The Medadvisor share price is soaring higher this week as the company announced its quarterly report. We take a closer…

    Read more »

    A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.
    Share Gainers

    Why the MedAdvisor (ASX:MDR) share price is pushing higher today

    The MedAdvisor Ltd (ASX:MDR) share price is pushing higher on Monday after upgrading its guidance thanks to a stronger than…

    Read more »

    ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

    2 ASX small cap healthcare shares growing quickly

    Avita Medical Ltd (ASX:AVH) and this ASX small cap healthcare share have been growing quickly in FY 2021...

    Read more »

    Share Fallers

    Why Afterpay, Goodman, MedAdvisor, & PointsBet shares are dropping lower

    Afterpay Ltd (ASX:APT) and Goodman Group (ASX:GMG) shares are two of four dropping lower on Tuesday. Here's why...

    Read more »

    a smiling doctor looks at her computer screen with medical imaging X-rays on a light screen in the background.
    Share Gainers

    Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday

    The MedAdvisor Ltd (ASX:MDR) share price was a strong performer on Friday and jumped as much as 9% higher. Here's…

    Read more »

    Share Market News

    MedAdvisor Ltd (ASX:MDR) share price halted ahead of transformational $49 million acquisition

    The MedAdvisor Ltd (ASX:MDR) share price is in a trading halt as it prepares to make a transformation acquisition...

    Read more »

    MDR ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About MedAdvisor Ltd

    MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has five reporting segments: ANZ Operations, USA Operations, UK Operations, Asia Operations, and Corporate. The company derives majority of its revenues from AU Operations.

    MDR Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 May 2024 $0.34 $0.00 0.00% 120,048 $0.34 $0.34 $0.34
    16 May 2024 $0.34 $-0.01 -2.94% 430,655 $0.34 $0.34 $0.33
    15 May 2024 $0.34 $0.01 3.03% 1,064,667 $0.34 $0.34 $0.33
    14 May 2024 $0.33 $0.00 0.00% 513,211 $0.33 $0.34 $0.33
    13 May 2024 $0.33 $0.00 0.00% 77,284 $0.33 $0.33 $0.33
    10 May 2024 $0.33 $0.00 0.00% 4,243,016 $0.33 $0.33 $0.32
    09 May 2024 $0.33 $0.00 0.00% 376,354 $0.33 $0.33 $0.32
    08 May 2024 $0.33 $0.02 6.35% 632,336 $0.32 $0.33 $0.32
    07 May 2024 $0.32 $0.01 3.23% 130,774 $0.31 $0.32 $0.31
    06 May 2024 $0.31 $0.00 0.00% 36,125 $0.31 $0.31 $0.30
    03 May 2024 $0.31 $0.01 3.28% 439,682 $0.31 $0.31 $0.30
    02 May 2024 $0.31 $0.01 3.33% 406,118 $0.30 $0.31 $0.29
    01 May 2024 $0.30 $0.00 0.00% 71,066 $0.30 $0.30 $0.29
    30 Apr 2024 $0.30 $0.01 3.39% 551,628 $0.30 $0.30 $0.29
    29 Apr 2024 $0.30 $0.00 0.00% 98,210 $0.30 $0.30 $0.30
    26 Apr 2024 $0.30 $-0.01 -3.28% 162,929 $0.30 $0.30 $0.29
    24 Apr 2024 $0.31 $0.02 6.90% 83,089 $0.31 $0.31 $0.29
    23 Apr 2024 $0.29 $0.02 7.41% 1,412,747 $0.29 $0.32 $0.27
    22 Apr 2024 $0.27 $0.01 3.85% 228,088 $0.26 $0.27 $0.26

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Nov 2023 Jim Xenos Sell 6,846,955 $1,232,452
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catherine (Kate) Jane Hill Non-Executive Director May 2023
    Ms Hill is auditor and business advisor with over 30 years' experience of working with privately owned and ASX-listed companies across a range of business issues. A former senior partner and first female board member of top 4 accounting firm Deloitte, she has in recent years turned her focus, her energies, and experience into Non-Executive Director roles. She is an director of small to mid-cap companies listed on ASX and other global exchanges, with a track record in change involving new business models, new markets, and new technologies. She is chair of Risk Committee amd member of People Committee.
    Mr Jim Xenos Non-Executive Director Nov 2015
    Mr Xenos is currently the Chief Executive Officer of NostraData Pty Limited, which he co-founded in 2010. Prior to co-founding NostraData, Jim held several Associate Director positions with GlaxoSmithKline PLC. Jim was also the Head of Retail at Sigma Healthcare Limited for Herron Pharmaceuticals. She is a member of Audit committee and chair of people committee.
    Ms Linda Jenkinson Non-Executive ChairmanNon-Executive Director Feb 2022
    Ms Jenkinson has 30 years of executive management, strategic consulting, and governance experience. She was the Co-founder and CEO of two technology-enabled companies, DMSC and LesConcierges. She is an experienced CEO who was the first woman CEO/ Co-founder to take her company public on the NASDAQ. She sold her second company to the Accor Hotel Group in 2016. Prior to DMSC, Linda was a Partner at A.T. Kearney, where she helped build their global Financial Institutions Practice. During the last three years, Linda served on the Board of Air New Zealand. She is a member of the Risk and People Committee.
    Ms Sandra Margaret Hook Non-Executive Director Jan 2016
    Ms Hook is an experienced board director with a non-executive career spanning diverse sectors including communications; IT, technology, and digital; health tech; tourism; government; research; and policy. She brings experience in transformation and growth gained in roles including Managing Director, CEO, COO, and marketing director for some of Australia's largest media organisations, including News Limited, Foxtel, and FairFax. Sandra's board experience spans listed, private, and government boards. She is Chair of Risk Committee.
    Mr Lucas Merrow Non-Executive Director Aug 2021
    Mr Merrow co-founded and served as the Chief Executive Officer of Eliza Corporation-the leader in health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the Chief Operating Officer of Adheris Health, a leading firm in prescription adherence and patient education programs in the United States. MedAdvisor acquired Adheris Health in November 2020. He is Member of People Committee.
    Mr Richard (Rick) Ratliff Chief Executive OfficerManaging Director Jul 2022
    Mr Ratliff spent over 30 years in the healthcare and pharmaceutical technology sector in key markets in which MedAdvisor Solutions operates. He has led the development of a number of large-scale technology-enabled healthcare businesses within global organisations such as IBM and Accenture as well as via start-up and early-stage businesses, including Healthvision, Surescripts, and ConnectiveRx. Rick also worked with the Australian federal government to develop and deliver My Health Record, the leading online EHR available to all Australian citizens. He is a member of People Committee.
    Mr Anthony Tassone Non-Executive Director Jul 2022
    Mr Tassone is a community pharmacist and has been a proprietor of community pharmacies since 2006 in outer southeastern Melbourne. He has been the Victorian Branch President of the Pharmacy Guild of Australia since 2013. Over the past decade, Anthony has served on a range of advisory boards for multinational pharmaceutical companies and had advisory roles with state and federal governments. In 2021, Anthony was appointed the National Vice President of Health Economics and Policy for the Pharmacy Guild of Australia. He is a member of Risk Committee.
    Mr Kevin Hutchinson Non-Executive Director Nov 2022
    Mr Hutchinson is an entrepreneur with 30 years of experience in the tech industry. He has built and grown companies that deliver innovative services by using disruptive technology. He also has seen great success in his ability to accelerate growth by hiring and developing teams that drive exceptional results. He has served in numerous C-level executive roles, including CEO and COO, as well as a number of non-executive board appointments. Kevin is CEO and Director of AXL Health and on the Board of Matrix Analytics dba eon Health. He is a member of Risk Committee.
    Mr Brett Magun Non-Executive Director May 2023
    Mr Magun has over 20 years of experience as a diversified attorney licensed to practice in Massachusetts and New York. He provides legal advice to C-level suite and boards of directors regarding strategic corporate transactions. His legal background includes M&A, strategic partnerships, employment issues, vendor contracts and management, privacy and regulatory compliance, pre-litigation and risk management, intellectual property (IP), marketing, external communications, and general legal matters.
    Ms Ancila Desai Chief Financial OfficerCompany Secretary Feb 2023
    Mr Anshu Raghuvanshi Joint Company Secretary Mar 2023
    Ancila Desai Chief Financial OfficerCompany Secretary
    Anshu Raghuvanshi Joint Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Guild Group Holdings Limited 94,905,130 17.38%
    National Nominees Limited 68,036,011 12.46%
    Hsbc Custody Nominees (Australia) Limited 47,308,994 8.66%
    Cotiviti Inc 43,999,999 8.06%
    Citicorp Nominees Pty Limited 37,328,343 6.84%
    J P Morgan Nominees Australia Pty Limited 30,623,011 5.61%
    Ebos Ph Pty Ltd 26,459,627 4.85%
    Bond Street Custodians Limited <Salter D79836 A/C> 17,320,000 3.17%
    Kojent Pty Ltd <Kojent A/C> 13,693,911 2.51%
    Romida Enterprises Pty Ltd <Romida Family A/C> 12,642,935 2.32%
    Wavey Industries Pty Ltd <Josh Swinnerton Family A/C> 10,785,259 1.97%
    UBS Nominees Pty Ltd 8,865,658 1.62%
    Indcorp Consulting Group Pty Limited <Superannuation Fund A/C> 5,000,000 0.92%
    Bnp Paribas Noms Pty Ltd <Drp> 4,505,429 0.82%
    Gread Management Pty Limited <The A G & R R Family A/C> 4,106,188 0.75%
    Provare Pty Ltd <Provare Investment A/C> 3,743,419 0.69%
    Dr Christopher Harold Benton 3,000,000 0.55%
    Tagdime Pty Ltd <Ian M Davison P/L S/F A/C> 2,634,322 0.48%
    DMX Capital Partners Limited 2,351,551 0.43%
    Capital Concerns Pty Limited <Logue Family Super Fund A/C> 2,197,092 0.40%